UnitedHealth Group Stock Holds Steady After Strong Q2 Earnings Report

UnitedHealth Group's stock has held steady at $393.99 as of August 28, 2026, following its Q2 earnings beat and higher EPS guidance. The company reported a profit of $6.38 per share, exceeding the consensus estimate by $1.44. This outperformance underscores UnitedHealth Group's ability to manage medical costs and administrative expenses effectively.

The revenue figure for Q2 2026 was $112.03 billion, a modest increase of 0.4% compared to the same quarter in the prior year. The company also set its fiscal 2026 guidance range at $19.500 to $20.000 in earnings per share, which implies meaningful year-over-year growth.

The stock carries a consensus rating of Moderate Buy, with an average price target of $456.56 for the shares. This suggests an upside potential of around 15.9% from the current price level if the average target is reached. However, some analysts have expressed caution due to regulatory risk and future medical-cost trends.